- Molecular NameMethsuximide
- Synonym(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; 1,3-Dimethyl-3-phenylsuccinimide; Alpha-methyl-alpha-phenyl n-methyl succinimide; Alpha-methylphensuximide; Mesuximida [inn-spanish]; Mesuximide; Mesuximidum [inn-latin]; Methsuximid; Metosuccimmide [DCIT]; Metsuccimide; N-methyl-alpha-methyl-alpha-phenylsuccinimide; N,2-Dimethyl-2-phenylsuccinimide
- Weight203.241
- Drugbank_IDDB05246
- ACS_NO77-41-8
- Show 2D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)1.67
- pkaN/A
- LogD (pH=7, predicted)1.67
- Solubility (experiment)2.86 mg/ml
- LogS (predicted, ACD/Labs)(ph=7)-2.1
- LogSw (predicted, AB/LogsW2.0)3.26
- Sw (mg/ml) (predicted, ACD/Labs)1.63
- No.of HBond Donors0
- No.of HBond Acceptors3
- No.of Rotatable Bonds1
- TPSA37.38
- StatusFDA approved
- AdministrationN/A
- PharmacologyAn succinimide anticonvulsant medication.
- Absorption_value100.0
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmHepatic (demethylation and glucuronidation)
- Half life1.4~2.6 h (mesuximide), 28~38 h (active metabolite)
- ExcretionRenal
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A